Clinical trial
An Observational Cohort Study to Determine Late Outcomes and Immunological Responses After Infection With SARS-CoV-2 in Children With and Without Multisystem Inflammatory Syndrome (MIS-C)
NCT04588363 is registered in ClinicalTrials.gov with National Institute of Allergy and Infectious Diseases (NIAID) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Observational Cohort Study to Determine Late Outcomes and Immunological Responses After Infection With SARS-CoV-2 in Children With and Without Multisystem Inflammatory Syndrome (MIS-C)
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 19, 2020
- Completion date
- March 3, 2023
- Enrollment
- 244 (actual)
- Sites
- 20
Conditions
As the registry lists them; a condition with its own page is linked.
coronavirus disease 2019 (covid-19), multisystem inflammatory syndrome in children (mis-c), severe acute respiratory syndrome coronavirus 2 (sars-cov-2)